Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program LeadershipBrian DeSchuytner named SVP and Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace
Mersana Therapeutics Announces Appointment of Tushar Misra, Ph D , as Chief Manufacturing Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer
April 26, 2021 08:00 ET | Source: Mersana Therapeutics, Inc. Mersana Therapeutics, Inc. Cambridge, Massachusetts, UNITED STATES
CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer.
“With our UPLIFT strategy now underway for UpRi and our growing pipeline of product candidates derived from our innovative ADC platforms, we are thrilled to have Alejandra join the team at this time of immense growth,” said Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics. “Alejand
Published: Mar 11, 2021
CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) Mersana Therapeutics, Inc.. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the appointment of Allene Diaz to its board of directors.
“Allene’s breadth of knowledge in strategic product planning, portfolio management and commercialization of cancer therapeutics will be invaluable to Mersana as we focus on building UpRi as a foundational therapy for the treatment of ovarian cancer and building out our maturing pipeline of ADC candidates. With our growing portfolio of product candidates, the strategic choices we make to create differentiated product labeling and positioning are critical to our vision of discovering and developing life-changing ADC therapies for patients fighting cancer. We are excited to benefit from Allene’s experienc